Abstract
The emergence of resistant strains of bacteria is directly related to the selection of chemotherapeutic agents, and the character of the resistance changes with changes in usefrequency of the various antibiotics. In recent years with increasing use of beta-lactam antibiotics, there has been an increased incidence of microorganisms that are resistant by virtue of their ability to produce beta-lactamase enzymes which destroy the beta-lactam antibiotics. The development of beta-lactamase inhibitors which may be used in combination with the beta-lactam antibiotics has been a significant advance for the therapy of gynecologic infections in South America.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Gynecology and Obstetrics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
